Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Strasbourg, France & Schiphol, Netherlands, Apr 3, 2026 – (JCN Newswire via SeaPRwire.com) – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based imดำเนินการต่อ

















